Abstract
The prevalence of myopia has increased substantially in recent decades and has approached 20–50% and 60–80% in the West and far East Asia, respectively. Worldwide, the condition is considered to be the leading cause of visual impairment. Therefore, finding effective treatment options for the control of myopia progression in children is both appealing and demanding. Several treatment therapies, including pharmaceutical agents; bifocal & multifocal spectacle lenses, and conventional, single vision GP & soft contact lenses have been used with relatively modest success to reduce myopia progression. Overall, most therapies have either limited treatment benefits or there are professional issues with regard to long-term prescribing of pharmaceutical agents. Recently, modern orthokeratology has been shown to be effective in slowing myopia progression in children.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
